Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons

Psychiatric disorders have clear heritable risk. Several large-scale genome-wide association studies have revealed a strong association between susceptibility for psychiatric disorders, including bipolar disease, schizophrenia and major depression, and a haplotype located in an intronic region of the L-type voltage-gated calcium channel (VGCC) subunit gene CACNA1C (peak associated SNP rs1006737), making it one of the most replicable and consistent associations in psychiatric genetics. In the current study, we used induced human neurons to reveal a functional phenotype associated with this psychiatric risk variant. We generated induced human neurons, or iN cells, from more than 20 individuals harboring homozygous risk genotypes, heterozygous or homozygous non-risk genotypes at the rs1006737 locus. Using these iNs, we performed electrophysiology and quantitative PCR experiments that demonstrated increased L-type VGCC current density as well as increased mRNA expression of CACNA1C in iNs homozygous for the risk genotype, compared with non-risk genotypes. These studies demonstrate that the risk genotype at rs1006737 is associated with significant functional alterations in human iNs, and may direct future efforts at developing novel therapeutics for the treatment of psychiatric disease.

[1]  Manuel A. R. Ferreira,et al.  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.

[2]  P. Navarra,et al.  Electrophysiological and molecular evidence of L‐(Cav1), N‐ (Cav2.2), and R‐ (Cav2.3) type Ca2+ channels in rat cortical astrocytes , 2004, Glia.

[3]  Eric M. Blalock,et al.  Decreased G-Protein-Mediated Regulation and Shift in Calcium Channel Types with Age in Hippocampal Cultures , 1999, The Journal of Neuroscience.

[4]  N. Klugbauer,et al.  Dihydropyridine enantiomers block recombinant L‐type Ca2+ channels by two different mechanisms , 1999, The Journal of physiology.

[5]  P. Sklar,et al.  Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association. , 2014, Bipolar disorders.

[6]  Ulrich Pfisterer,et al.  Direct conversion of human fibroblasts to dopaminergic neurons , 2011, Proceedings of the National Academy of Sciences.

[7]  W. Catterall,et al.  Cooperative regulation of Cav1.2 channels by intracellular Mg2+, the proximal C-terminal EF-hand, and the distal C-terminal domain , 2009, The Journal of general physiology.

[8]  T. Südhof,et al.  Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells , 2013, Neuron.

[9]  P. Janicak,et al.  Calcium channel antagonists for the treatment of bipolar disorder. , 2000, Bipolar disorders.

[10]  N. Craddock,et al.  Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk , 2009, Molecular Psychiatry.

[11]  Christian Thoresen,et al.  CACNA1C Risk Variant and Amygdala Activity in Bipolar Disorder, Schizophrenia and Healthy Controls , 2013, PloS one.

[12]  Joseph H Callicott,et al.  Genetic variation in CACNA1C affects brain circuitries related to mental illness. , 2010, Archives of general psychiatry.

[13]  S. Hyman,et al.  Progress in the Genetics of Polygenic Brain Disorders: Significant New Challenges for Neurobiology , 2013, Neuron.

[14]  Yong He,et al.  The association of genetic variation in CACNA1C with structure and function of a frontotemporal system. , 2011, Bipolar disorders.

[15]  M. Takahashi,et al.  Tyr13 is essential for the binding of omega-conotoxin MVIIC to the P/Q-type calcium channel. , 1995, Biochemical and biophysical research communications.

[16]  Elo Leung,et al.  A TALE nuclease architecture for efficient genome editing , 2011, Nature Biotechnology.

[17]  B. Bean,et al.  omega-Conotoxin block of N-type calcium channels in frog and rat sympathetic neurons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  Peter Kirsch,et al.  Brain function in carriers of a genome-wide supported bipolar disorder variant. , 2010, Archives of general psychiatry.

[19]  Thomas Vierbuchen,et al.  Direct conversion of fibroblasts to functional neurons by defined factors , 2010, Nature.

[20]  Michael E. Greenberg,et al.  From Synapse to Nucleus: Calcium-Dependent Gene Transcription in the Control of Synapse Development and Function , 2008, Neuron.

[21]  Chunyu Liu,et al.  A rare mutation of CACNA1C in a patient with Bipolar disorder, and decreased gene expression associated with a Bipolar-associated common SNP of CACNA1C in brain , 2013, Molecular Psychiatry.

[22]  Thomas Vierbuchen,et al.  Induction of human neuronal cells by defined transcription factors , 2011, Nature.

[23]  K Mathiak,et al.  Effects of a CACNA1C genotype on attention networks in healthy individuals , 2010, Psychological Medicine.

[24]  A. Farmer,et al.  Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable finding , 2009, Psychological Medicine.

[25]  William A. Catterall,et al.  International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels , 2005, Pharmacological Reviews.

[26]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[27]  Feng Zhang,et al.  CRISPR-assisted editing of bacterial genomes , 2013, Nature Biotechnology.

[28]  E. Vassos,et al.  Initial evidence for the role of CACNA1C on subcortical brain morphology in patients with bipolar disorder , 2011, European Psychiatry.

[29]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[30]  L. Tsai,et al.  DISC1–ATF4 transcriptional repression complex: dual regulation of the cAMP-PDE4 cascade by DISC1 , 2013, Molecular Psychiatry.

[31]  Kazuki Sato,et al.  Tyr13 Is Essential for the Binding of ω-Conotoxin MVIIC to the P/Q-Type Calcium Channel , 1995 .

[32]  R. Post,et al.  The Efficacy and Use of Anticonvulsants in Mood Disorders , 1998, Clinical neuropharmacology.

[33]  Qi Dong,et al.  The Effects of CACNA1C Gene Polymorphism on Spatial Working Memory in Both Healthy Controls and Patients with Schizophrenia or Bipolar Disorder , 2012, Neuropsychopharmacology.

[34]  박찬영.  Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome , 2012 .

[35]  M C O'Donovan,et al.  The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia , 2009, Molecular Psychiatry.

[36]  T. Werge,et al.  CACNA1C (rs1006737) is associated with schizophrenia , 2010, Molecular Psychiatry.

[37]  L. Tsai,et al.  DISC 1 – ATF 4 transcriptional repression complex : dual regulation of the cAMP-PDE 4 cascade by DISC 1 , 2013 .

[38]  B. MacVicar,et al.  Expression of voltage‐gated Ca2+ channel subtypes in cultured astrocytes , 2003, Glia.

[39]  Rudolf Jaenisch,et al.  One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[40]  Panos Roussos,et al.  The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males , 2011, Bipolar disorders.

[41]  M. Wallace.  Calcium channel antagonists for the treatment of pain , 2002 .

[42]  Guillén Fernández,et al.  Genetic Variation in CACNA1C, a Gene Associated with Bipolar Disorder, Influences Brainstem Rather than Gray Matter Volume in Healthy Individuals , 2010, Biological Psychiatry.

[43]  P M Visscher,et al.  Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses , 2012, Molecular Psychiatry.